Disruption of 5-HT2A Receptor-PDZ Protein Interactions Alleviates Mechanical Hypersensitivity in Carrageenan-Induced Inflammation in Rats

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Wattiez, Anne Sophie ^a,b   Pichon, Xavier ^a,b   Dupuis, Amandine ^a,b   Hernández, Alejandro ^c   Privat, Anne Marie ^a,b   Aissouni, Youssef ^a,b   Chalus, Maryse ^a,b   Pelissier, Teresa ^d   Eschalier, Alain ^a,b,e   Marin, Philippe ^f,g   Courteix, Christine ^a,b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b INSERM   (France)

^c UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^f UNIV MONTPELLIER   (France)

^g INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BICUCULLINE; CARRAGEENAN; FLUOXETINE; PDZ PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; SEROTONIN 2A RECEPTOR; TAT 2ASCV PEPTIDE; UNCLASSIFIED DRUG; VOLINANSERIN; DLGH4 PROTEIN, RAT; FLUOROBENZENE; MEMBRANE PROTEIN; PEPTIDE; PIPERIDINE DERIVATIVE; SEROTONIN 2 ANTAGONIST; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INFLAMMATORY PAIN; INTERNEURON; MALE; NONHUMAN; RAT; SPINAL CORD DORSAL HORN; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; INFLAMMATION; INJECTION; METABOLISM; PAIN; PATHOLOGY; POSTERIOR HORN CELL; PROTEIN BINDING; SPRAGUE DAWLEY RAT;

ANIMALS; BICUCULLINE; CARRAGEENAN; FLUOROBENZENES; FLUOXETINE; HYPERALGESIA; INFLAMMATION; INJECTIONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; PAIN; PEPTIDES; PIPERIDINES; POSTERIOR HORN CELLS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS;

EID: 84884232546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074661     Document Type: Article

References (40)

1. Xu Q, Yaksh TL, (2011) A brief comparison of the pathophysiology of inflammatory versus neuropathic pain. Curr Opin Anaesthesiol 24: 400-407. doi:10.1097/ACO.0b013e32834871df. PubMed: 21659872.
2. van Laar M, Pergolizzi JV Jr., Mellinghoff HU, Merchante IM, Nalamachu S, et al. (2012) Pain treatment in arthritis-related pain: beyond NSAIDs. Open Rheumatol J 6: 320-330. doi:10.2174/1874312901206010320. PubMed: 23264838.
3. Finnerup NB, Sindrup SH, Jensen TS, (2010) Recent advances in pharmacological treatment of neuropathic pain. F1000 Med Rep. 2: 52.
4. Eschalier A, Courteix C, (2007) [Antidepressants and pain]. Rev Med Suisse 3: 1581-1584. PubMed: 17727169.
5. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS, (2000) Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med 1: 310-316. doi:10.1046/j.1526-4637.2000.00042.x. PubMed: 15101877.
6. Sawynok J, Esser MJ, Reid AR, (1999) Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 82: 149-158. doi:10.1016/S0304-3959(99)00043-3. PubMed: 10467920.
7. Millan MJ, (2002) Descending control of pain. Prog Neurobiol 66: 355-474. doi:10.1016/S0301-0082(02)00009-6. PubMed: 12034378.
8. Zhao ZQ, Chiechio S, Sun YG, Zhang KH, Zhao CS, et al. (2007) Mice lacking central serotonergic neurons show enhanced inflammatory pain and an impaired analgesic response to antidepressant drugs. J Neurosci 27: 6045-6053. doi:10.1523/JNEUROSCI.1623-07.2007. PubMed: 17537976.
9. Liu FY, Xing GG, Qu XX, Xu IS, Han JS, et al. (2007) Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats. J Pharmacol Exp Ther 321: 1046-1053. doi:10.1124/jpet.106.115204. PubMed: 17329553.
10. Okamoto K, Imbe H, Kimura A, Donishi T, Tamai Y, et al. (2007) Activation of central 5HT2A receptors reduces the craniofacial nociception of rats. Neuroscience 147: 1090-1102. doi:10.1016/j.neuroscience.2007.05.012. PubMed: 17582689.
11. Sasaki M, Obata H, Saito S, Goto F, (2003) Antinociception with intrathecal alpha-methyl-5-hydroxytryptamine, a 5-hydroxytryptamine 2A/2C receptor agonist, in two rat models of sustained pain. Anesth Analg 96: 1072-1078. PubMed: 12651663.
12. Obata H, Saito S, Sasaki M, Goto F, (2003) Interactions of 5-HT2 receptor agonists with acetylcholine in spinal analgesic mechanisms in rats with neuropathic pain. Brain Res 965: 114-120. doi:10.1016/S0006-8993(02)04145-8. PubMed: 12591127.
13. Obata H, Saito S, Sasaki M, Ishizaki K, Goto F, (2001) Antiallodynic effect of intrathecally administered 5-HT(2) agonists in rats with nerve ligation. Pain 90: 173-179. doi:10.1016/S0304-3959(00)00401-2. PubMed: 11166984.
14. Sasaki M, Ishizaki K, Obata H, Goto F, (2001) Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur J Pharmacol 424: 45-52. doi:10.1016/S0014-2999(01)01117-7. PubMed: 11470259.
15. Honda M, Uchida K, Tanabe M, Ono H, (2006) Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A/2C receptors. Neuropharmacology 51: 866-872. doi:10.1016/j.neuropharm.2006.05.031. PubMed: 16846619.
16. Anjaneyulu M, Chopra K, (2004) Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice. Eur J Pharmacol 497: 285-292. doi:10.1016/j.ejphar.2004.06.063. PubMed: 15336946.
17. Yokogawa F, Kiuchi Y, Ishikawa Y, Otsuka N, Masuda Y, et al. (2002) An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg 95: 163-168. doi:10.1097/00000539-200207000-00029. PubMed: 12088962.
18. Jones KA, Srivastava DP, Allen JA, Strachan RT, Roth BL, et al. (2009) Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling. Proc Natl Acad Sci U S A 106: 19575-19580. doi:10.1073/pnas.0905884106. PubMed: 19889983.
19. Allen JA, Yadav PN, Roth BL, (2008) Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases. Neuropharmacology 55: 961-968. doi:10.1016/j.neuropharm.2008.06.048. PubMed: 18640136.
20. Bécamel C, Gavarini S, Chanrion B, Alonso G, Galéotti N, et al. (2004) The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins. J Biol Chem 279: 20257-20266. doi:10.1074/jbc.M312106200. PubMed: 14988405.
21. Pichon X, Wattiez AS, Becamel C, Ehrlich I, Bockaert J, et al. (2010) Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain. Mol Ther 18: 1462-1470. doi:10.1038/mt.2010.101. PubMed: 20531396.
22. Andreasen JT, Bach A, Gynther M, Nasser A, Mogensen J, et al. (2013) UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801. Neuropharmacology 67: 193-200. doi:10.1016/j.neuropharm.2012.11.006. PubMed: 23178182.
23. Tao F, Su Q, Johns RA, (2008) Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits chronic inflammatory pain behaviors in mice. Mol Ther 16: 1776-1782. doi:10.1038/mt.2008.192. PubMed: 18781143.
24. Zhang B, Tao F, Liaw WJ, Bredt DS, Johns RA, et al. (2003) Effect of knock down of spinal cord PSD-93/chapsin-110 on persistent pain induced by complete Freund's adjuvant and peripheral nerve injury. Pain 106: 187-196. doi:10.1016/j.pain.2003.08.003. PubMed: 14581127.
25. Zimmermann M, (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110. doi:10.1016/0304-3959(83)90201-4. PubMed: 6877845.
26. Winter CA, Flataker L, (1965) Reaction thresholds to pressure in edematous hindpaws of rats and responses to analgesic drugs. J Pharmacol Exp Ther 150: 165-171. PubMed: 5853697.
27. Kayser V, Guilbaud G, (1987) Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rat. Pain 28: 99-107. doi:10.1016/0304-3959(87)91064-5. PubMed: 3822499.
28. Mestre C, Pélissier T, Fialip J, Wilcox G, Eschalier A, (1994) A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods 32: 197-200. doi:10.1016/1056-8719(94)90087-6. PubMed: 7881133.
29. Iwasaki T, Otsuguro K, Kobayashi T, Ohta T, Ito S, (2013) Endogenously released 5-HT inhibits A and C fiber-evoked synaptic transmission in the rat spinal cord by the facilitation of GABA/glycine and 5-HT release via 5-HT(2A) and 5-HT(3) receptors. Eur J Pharmacol 702: 149-157. doi:10.1016/j.ejphar.2013.01.058. PubMed: 23399761.
30. Wang YY, Wei YY, Huang J, Wang W, Tamamaki N, et al. (2009) Expression patterns of 5-HT receptor subtypes 1A and 2A on GABAergic neurons within the spinal dorsal horn of GAD67-GFP knock-in mice. J Chem Neuroanat 38: 75-81. doi:10.1016/j.jchemneu.2009.04.003. PubMed: 19409978.
31. Devor M, Wall PD, (1978) Reorganisation of spinal cord sensory map after peripheral nerve injury. Nature 276: 75-76. doi:10.1038/276075a0. PubMed: 570248.
32. Woolf CJ, Doubell TP, (1994) The pathophysiology of chronic pain--increased sensitivity to low threshold A beta-fibre inputs. Curr Opin Neurobiol 4: 525-534. doi:10.1016/0959-4388(94)90053-1. PubMed: 7812141.
33. Raote I, Bhattacharyya S, Panicker MM, (2013) Functional selectivity in serotonin receptor 2A (5-HT2A) endocytosis, recycling, and phosphorylation. Mol Pharmacol 83: 42-50. doi:10.1124/mol.112.078626. PubMed: 23034456.
34. Zhang YQ, Gao X, Ji GC, Wu GC, (2001) Expression of 5-HT2A receptor mRNA in rat spinal dorsal horn and some nuclei of brainstem after peripheral inflammation. Brain Res 900: 146-151. doi:10.1016/S0006-8993(01)02283-1. PubMed: 11325358.
35. Zhang YQ, Gao X, Zhang LM, Wu GC, (2000) The release of serotonin in rat spinal dorsal horn and periaqueductal gray following carrageenan inflammation. Neuroreport 11: 3539-3543. doi:10.1097/00001756-200011090-00027. PubMed: 11095514.
36. Xia Z, Gray JA, Compton-Toth BA, Roth BL, (2003) A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction. J Biol Chem 278: 21901-21908. doi:10.1074/jbc.M301905200. PubMed: 12682061.
37. Perrot S, Maheu E, Javier RM, Eschalier A, Coutaux A, et al. (2006) Guidelines for the use of antidepressants in painful rheumatic conditions. Eur J Pain 10: 185-192. doi:10.1016/j.ejpain.2005.03.004. PubMed: 16490727.
38. Abdel-Salam OM, Baiuomy AR, Arbid MS, (2004) Studies on the anti-inflammatory effect of fluoxetine in the rat. Pharmacol Res 49: 119-131. doi:10.1016/j.phrs.2003.07.016. PubMed: 14643692.
39. Jones CK, Eastwood BJ, Need AB, Shannon HE, (2006) Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition. Neuropharmacology 51: 1172-1180. doi:10.1016/j.neuropharm.2006.08.005. PubMed: 17045620.
40. Bouzidi N, Deokar H, Vogrig A, Boucherle B, Ripoche I, et al. (2013) Identification of PDZ ligands by docking-based virtual screening for the development of novel analgesic agents. Bioorg Med Chem Lett 23: 2624-2627. doi:10.1016/j.bmcl.2013.02.100. PubMed: 23545111.